251 related articles for article (PubMed ID: 29784954)
1. The structural basis of nanobody unfolding reversibility and thermoresistance.
Kunz P; Zinner K; Mücke N; Bartoschik T; Muyldermans S; Hoheisel JD
Sci Rep; 2018 May; 8(1):7934. PubMed ID: 29784954
[TBL] [Abstract][Full Text] [Related]
2. Nanobody stability engineering by employing the ΔTm shift; a comparison with apparent rate constants of heat-induced aggregation.
Kunz P; Ortale A; Mücke N; Zinner K; Hoheisel JD
Protein Eng Des Sel; 2019 Dec; 32(5):241-249. PubMed ID: 31340035
[TBL] [Abstract][Full Text] [Related]
3. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
4. Exploiting sequence and stability information for directing nanobody stability engineering.
Kunz P; Flock T; Soler N; Zaiss M; Vincke C; Sterckx Y; Kastelic D; Muyldermans S; Hoheisel JD
Biochim Biophys Acta Gen Subj; 2017 Sep; 1861(9):2196-2205. PubMed ID: 28642127
[TBL] [Abstract][Full Text] [Related]
5. Nanobody engineering: computational modelling and design for biomedical and therapeutic applications.
El Salamouni NS; Cater JH; Spenkelink LM; Yu H
FEBS Open Bio; 2024 Jun; ():. PubMed ID: 38898362
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.
Goldman ER; Liu JL; Zabetakis D; Anderson GP
Front Immunol; 2017; 8():865. PubMed ID: 28791022
[TBL] [Abstract][Full Text] [Related]
7. Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.
Wang Y; Fan Z; Shao L; Kong X; Hou X; Tian D; Sun Y; Xiao Y; Yu L
Int J Nanomedicine; 2016; 11():3287-303. PubMed ID: 27499623
[TBL] [Abstract][Full Text] [Related]
8. Fenobody: A Ferritin-Displayed Nanobody with High Apparent Affinity and Half-Life Extension.
Fan K; Jiang B; Guan Z; He J; Yang D; Xie N; Nie G; Xie C; Yan X
Anal Chem; 2018 May; 90(9):5671-5677. PubMed ID: 29634235
[TBL] [Abstract][Full Text] [Related]
9. NanoLAS: a comprehensive nanobody database with data integration, consolidation and application.
Xiong S; Liu Z; Yi X; Liu K; Huang B; Wang X
Database (Oxford); 2024 Jan; 2024():. PubMed ID: 38300518
[TBL] [Abstract][Full Text] [Related]
10. Reversibility of heat-induced denaturation of the recombinant human megakaryocyte growth and development factor.
Narhi LO; Philo JS; Sun B; Chang BS; Arakawa T
Pharm Res; 1999 Jun; 16(6):799-807. PubMed ID: 10397597
[TBL] [Abstract][Full Text] [Related]
11. In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.
Vaneycken I; Govaert J; Vincke C; Caveliers V; Lahoutte T; De Baetselier P; Raes G; Bossuyt A; Muyldermans S; Devoogdt N
J Nucl Med; 2010 Jul; 51(7):1099-106. PubMed ID: 20554727
[TBL] [Abstract][Full Text] [Related]
12. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
Pain C; Dumont J; Dumoulin M
Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
[TBL] [Abstract][Full Text] [Related]
13. Extreme thermal stability of the antiGFP nanobody - GFP complex.
Kakasi B; Gácsi E; Jankovics H; Vonderviszt F
BMC Res Notes; 2023 Jun; 16(1):110. PubMed ID: 37340471
[TBL] [Abstract][Full Text] [Related]
14. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
15. Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein.
Anderson GP; Teichler DD; Zabetakis D; Shriver-Lake LC; Liu JL; Lonsdale SG; Goodchild SA; Goldman ER
PLoS One; 2016; 11(8):e0160534. PubMed ID: 27494523
[TBL] [Abstract][Full Text] [Related]
16. Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies.
Zuo J; Li J; Zhang R; Xu L; Chen H; Jia X; Su Z; Zhao L; Huang X; Xie W
BMC Genomics; 2017 Oct; 18(1):797. PubMed ID: 29041922
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the selection and identification of antigen-specific nanobodies.
Liu W; Song H; Chen Q; Yu J; Xian M; Nian R; Feng D
Mol Immunol; 2018 Apr; 96():37-47. PubMed ID: 29477934
[TBL] [Abstract][Full Text] [Related]
18. Domain swapping of complementarity-determining region in nanobodies produced by Pichia pastoris.
Miura N; Miyamoto K; Ohtani Y; Yaginuma K; Aburaya S; Kitagawa Y; Aoki W; Ueda M
AMB Express; 2019 Jul; 9(1):107. PubMed ID: 31309388
[TBL] [Abstract][Full Text] [Related]
19. A Two-Step Approach for the Design and Generation of Nanobodies.
Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
[TBL] [Abstract][Full Text] [Related]
20. Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains.
Ewert S; Cambillau C; Conrath K; Plückthun A
Biochemistry; 2002 Mar; 41(11):3628-36. PubMed ID: 11888279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
